192 results
S-8
EX-23.1
CKPT
Checkpoint Therapeutics Inc
24 May 24
Registration of securities for employees
4:06pm
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated March 22, 2024, with respect
S-8
CKPT
Checkpoint Therapeutics Inc
24 May 24
Registration of securities for employees
4:06pm
.
5.1
Opinion of Alston & Bird LLP.
23.1
Consent of KPMG LLP, Independent Registered Public Accounting Firm.
23.2
Consent of Alston & Bird LLP
S-8
EX-5.1
CKPT
Checkpoint Therapeutics Inc
24 May 24
Registration of securities for employees
4:06pm
expressly set forth herein, we have made no independent investigations with regard to matters of fact, and, accordingly, we do not express any opinion … as to matters that might have been disclosed by independent verification.
Our opinion set forth below is limited to the General Corporation Law
8-K
CKPT
Checkpoint Therapeutics Inc
14 May 24
Departure of Directors or Certain Officers
7:30am
as the Company’s independent registered public accounting firm for the year ending December 31, 2024; (iii) an amendment to the Company’s Amended … .
Barry Salzman
Amit Sharma, M.D.
Proposal 2
The votes with respect to the ratification of KPMG LLP as the Company’s independent registered accounting
8-K
EX-10.1
CKPT
Checkpoint Therapeutics Inc
14 May 24
Departure of Directors or Certain Officers
7:30am
of Section 422 of the Code or any successor provision thereto.
(x) “Independent Directors” means those members of the Board who qualify at any given … time as an “independent” director under the applicable rules of each Exchange on which the Shares are listed, as a “non-employee” director under Rule
DEFA14A
s6969zz gc
2 Apr 24
Additional proxy soliciting materials
6:03am
8-K
ftmfw1m5 c04qn
18 Mar 24
Checkpoint Therapeutics Announces Appointment of Accomplished Life Sciences Executive Amit Sharma, M.D. to Board of Directors
4:05pm
8-K
EX-99.1
ft4 ih69td6yv3m5bb42
18 Mar 24
Checkpoint Therapeutics Announces Appointment of Accomplished Life Sciences Executive Amit Sharma, M.D. to Board of Directors
4:05pm
8-K
rcpo2r70mhb mni8u
2 Feb 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:15pm
424B5
a9s2w1ac37
30 Jan 24
Prospectus supplement for primary offering
5:10pm
8-K
EX-4.2
dpuehjcdc5v9928p134q
30 Jan 24
Checkpoint Therapeutics Announces $14 Million Registered Direct Offering Priced At-the-Market
5:00pm